Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair
Open Access
- 2 October 2013
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 33 (40) , 4803-4812
Abstract
Heterozygous carriers of germ-line mutations in the BRCA2/FANCD1, PALB2/FANCN and RAD51C/FANCO DNA repair genes have an increased lifetime risk of developing breast, ovarian and other cancers; bi-allelic mutations in these genes clinically manifest as Fanconi anemia (FA). Here, we demonstrate that RAD51C is part of a novel protein complex that contains PALB2 and BRCA2. Further, the PALB2 WD40 domain can directly and independently bind RAD51C and BRCA2. To understand the role of these homologous recombination (HR) proteins in DNA repair, we functionally characterize effects of missense mutants of the PALB2 WD40 domain that have been reported in breast cancer patients. In contrast to large truncations of PALB2, which display a complete loss of interaction, the L939W, T1030I and L1143P missense mutants/variants of the PALB2 WD40 domain are associated with altered patterns of direct binding to the RAD51C, RAD51 and BRCA2 HR proteins in biochemical assays. Further, the T1030I missense mutant is unstable, whereas the L939W and L1143P proteins are stable but partially disrupt the PALB2–RAD51C–BRCA2 complex in cells. Functionally, the L939W and L1143P mutants display a decreased capacity for DNA double-strand break-induced HR and an increased cellular sensitivity to ionizing radiation. As further evidence for the functional importance of the HR complex, RAD51C mutants that are associated with cancer susceptibility and FA also display decreased complex formation with PALB2. Together, our results suggest that three different cancer susceptibility and FA proteins function in a DNA repair pathway based upon the PALB2 WD40 domain binding to RAD51C and BRCA2.Keywords
This publication has 56 references indexed in Scilit:
- Mutations in ERCC4, Encoding the DNA-Repair Endonuclease XPF, Cause Fanconi AnemiaThe American Journal of Human Genetics, 2013
- Molecular pathogenesis and clinical management of Fanconi anemiaJournal of Clinical Investigation, 2012
- Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk familiesFamilial Cancer, 2012
- The BRC Repeats of BRCA2 Modulate the DNA-Binding Selectivity of RAD51Cell, 2009
- Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer TherapyCurrent Cancer Drug Targets, 2009
- Genetic Predisposition to Breast Cancer: Past, Present, and FutureAnnual Review of Genomics and Human Genetics, 2008
- FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3Oncogene, 2008
- Analysis ofPALB2/FANCN-associated breast cancer familiesProceedings of the National Academy of Sciences, 2007
- A recurrent mutation in PALB2 in Finnish cancer familiesNature, 2007
- Ten Genes for Inherited Breast CancerCancer Cell, 2007